These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 16782163
1. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation. Jesser RD, Li S, Weinberg A. Virology; 2006 Sep 01; 352(2):408-17. PubMed ID: 16782163 [Abstract] [Full Text] [Related]
2. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M. Int Immunopharmacol; 2009 Jul 01; 9(7-8):831-6. PubMed ID: 19303058 [Abstract] [Full Text] [Related]
3. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy. Stone SF, Price P, French MA. HIV Med; 2005 Jul 01; 6(4):278-83. PubMed ID: 16011533 [Abstract] [Full Text] [Related]
4. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Weinberg A, Wohl DA, Barrett RJ, van der Horst C. J Infect Dis; 2001 Sep 15; 184(6):707-12. PubMed ID: 11517431 [Abstract] [Full Text] [Related]
5. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ. J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550 [Abstract] [Full Text] [Related]
6. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Mahic M, Henjum K, Yaqub S, Bjørnbeth BA, Torgersen KM, Taskén K, Aandahl EM. Eur J Immunol; 2008 Mar 01; 38(3):640-6. PubMed ID: 18266270 [Abstract] [Full Text] [Related]
7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI. Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945 [Abstract] [Full Text] [Related]
8. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D. J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261 [Abstract] [Full Text] [Related]
9. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology. Scherrenburg J, Schellens IM, van Baarle D. Antivir Ther; 2011 Mar 15; 16(4):565-75. PubMed ID: 21685544 [Abstract] [Full Text] [Related]
10. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA. HIV Med; 2004 Nov 15; 5(6):407-14. PubMed ID: 15544692 [Abstract] [Full Text] [Related]
11. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. Bronke C, Westerlaken GH, Miedema F, Tesselaar K, van Baarle D. Immunol Lett; 2005 Mar 15; 97(2):215-24. PubMed ID: 15752561 [Abstract] [Full Text] [Related]
12. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group. J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038 [Abstract] [Full Text] [Related]
13. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity. Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D. Antivir Ther; 2006 Dec 01; 11(1):105-16. PubMed ID: 16518966 [Abstract] [Full Text] [Related]
14. Excess apoptosis of mononuclear cells contributes to the depressed cytomegalovirus-specific immunity in HIV-infected patients on HAART. Weinberg A, Jesser RD, Edelstein CL, Bill JR, Wohl DA. Virology; 2004 Dec 05; 330(1):313-21. PubMed ID: 15527856 [Abstract] [Full Text] [Related]
15. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM. Virology; 2001 Jan 20; 279(2):459-70. PubMed ID: 11162802 [Abstract] [Full Text] [Related]
16. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells. López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM. Eur J Immunol; 2008 Jun 20; 38(6):1548-58. PubMed ID: 18421792 [Abstract] [Full Text] [Related]
17. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy. Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM. J Infect Dis; 2012 May 15; 205(10):1501-9. PubMed ID: 22457273 [Abstract] [Full Text] [Related]
18. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Gaardbo JC, Nielsen SD, Vedel SJ, Ersbøll AK, Harritshøj L, Ryder LP, Nielsen JO, Kolte L. Clin Exp Immunol; 2008 Oct 15; 154(1):80-6. PubMed ID: 18821942 [Abstract] [Full Text] [Related]